Small molecules target mitochondrial DNA depletion to treat energy-related diseases
Inside Precision Medicine - 10-Apr-2025Their compound PZL-A shows promise and a related drug has entered trials
Join the club for FREE to access the whole archive and other member benefits.
Science Translator and Senior Editor at GEN News
Jonathan Grinstein is a Senior Editor at Mary Anne Liebert Publishers, writing feature articles for several in-house outlets, including magazines Genetic Engineering & Biotechnology News (GEN) and Inside Precision Medicine as well as GEN Biotechnology, and producing a podcast that is currently in development. He has 10 years of experience in experimental and computational research, during which he was a co-author on research articles in journals such as Nature and Cell.
His interest for the human mind and body led him to an undergraduate education in Neural Science and Philosophy and a doctorate in Biomedical Sciences.
Visit website: https://jonathandgrinstein.com/
jonathan-d-grinstein-phd-14424184
See alsoDetails last updated 27-Oct-2023
Their compound PZL-A shows promise and a related drug has entered trials
New AI technologies promise to accelerate scientific discoveries and cure diseases by the end of the century